GCMI-T3 Labs will be exhibiting at the Society of Interventional Radiology annual meeting (Booth 833), which will be held March 17-22, 2018 in sunny Los Angeles, CA. This is a great opportunity to learn about the latest clinical and scientific contributions as well as current treatments, needs and future trends in interventional radiology. We look forward to networking with radiologists and peers from around the world, offering unique perspectives on this rapidly growing specialty.

Among the presentations offered this year, we at T3 Labs are especially interested in:
Sunday March 18th
8:00 AM – 10:00 AM Cool IR Therapies From Around The World That You Don’t Know…Yet
1:00 PM – 2:30 PM Renal Ablation – Options and Optimization
3:00 PM – 4:30 PM Venous IVC Filter

Monday March 19th
8:00 AM – 10:00 AM Engineering Moonshot Technologies to Advance IR Tuesday March 20th
8:00 am – 10:00 am Medical Device Innovation
You can view the full conference program and agenda here.

Our bags are packed. Let’s connect in LA!

T3 Labs provides medical device testing and bioskills training for more than 2,000 physicians, medical device sales force members, students and other allied healthcare professionals every year.

In our sponsors’ own words
“Being confident that our preclinical CRO partner T3 Labs delivers thorough GLP reports that generate regulatory clearances as swiftly as possible is immensely valuable to us.” – Surefire Medical

Read more about how Surefire gained FDA 510(k) clearance twice as fast as the industry average.

“The T3 Labs team is fluent in our scientific language. Because of this, I’m able to do a much better job and I can entrust them to communicate with the physicians directly.” – Cook Medical

If you are an early stage medical technology company or an innovator and want to talk about your product’s path to regulatory approval, including design and development or you are ready to engage the preclinical process, we want to connect with you at SIR 2018! Contact Deepal Panchal to set up a meeting or stop by booth 833.